Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
CagriSema CagriSema is an investigational fixed-dose combination of cagrilintide, a long-acting amylin analog, and semaglutide, a GLP-1 receptor agonist, co-administered once weekly and studied in Phase 3 trials for obesity and type 2 diabetes.
Reconstituted with 2.5 mL bacteriostatic water for a 6.0 mg/mL total-blend concentration
So what are we aiming for
Some supplements may include additional ingredients such as vitamin C, alpha-lipoic acid, or other antioxidants to enhance their efficacy
US$ 29.36
US$ 27.18
US$ 28.20
